Insuran Nph

Insuran NPH: medium-acting insulin produced in Russia

Insuran NPH is one of the modern insulins of medium duration of action, which is produced in Russia. This drug is the result of scientific research at the Institute of Bioorganic Chemistry named after. Ak. MM. Shemyakin and Yu.A. Ovchinnikov RAS.

Insuran NPH belongs to the group of intermediate-acting insulins that are used to treat diabetes mellitus. It contains the same hormone - insulin, as its foreign analogues, but is produced in Russia.

The international name of insulin Insuran NPH is Insulin-isophane (human genetically engineered). The drug is also known under various synonyms, such as Biosulin N, Gansulin N, Insulin Protafan HM penfill, Insulin Humulin N, Insuman Basal GT, Protafan HM, Protafan HM penfill, Humulin NPH, Humulin N, Humulin NPH, Humulin NPH, Humulin NPH.

Insuran NPH is available in several dosage forms, including 40 IU/mL injection solution, 40 IU/mL injection suspension, and 100 IU/mL subcutaneous injection suspension. These forms allow you to choose the most convenient way to use insulin depending on the needs of a particular patient.

According to the instructions for use, Insuran NPH is applied subcutaneously 1-2 times a day, 30-60 minutes before meals. The dosage and frequency of insulin use depend on the individual needs of the patient.

Intermediate-acting insulins, including Insuran NPH, are used to stabilize blood glucose levels over a long period of time. They help prevent sudden fluctuations in sugar levels and improve the quality of life of patients with diabetes.

Thus, Insuran NPH is a Russian medium-acting insulin that is available in several dosage forms and can be used to control blood glucose levels in patients with diabetes.